ZEPPOLA, TEA
 Distribuzione geografica
Continente #
AS - Asia 988
NA - Nord America 223
EU - Europa 136
SA - Sud America 75
AF - Africa 9
OC - Oceania 3
Totale 1.434
Nazione #
SG - Singapore 746
US - Stati Uniti d'America 211
CN - Cina 101
IT - Italia 85
HK - Hong Kong 72
BR - Brasile 58
VN - Vietnam 29
FR - Francia 14
GB - Regno Unito 11
AR - Argentina 9
DE - Germania 8
ID - Indonesia 6
IN - India 5
KR - Corea 5
MX - Messico 5
BD - Bangladesh 4
PK - Pakistan 4
AU - Australia 3
CA - Canada 3
CZ - Repubblica Ceca 3
FI - Finlandia 3
MA - Marocco 3
NL - Olanda 3
PY - Paraguay 3
CL - Cile 2
DO - Repubblica Dominicana 2
EE - Estonia 2
IQ - Iraq 2
JO - Giordania 2
PH - Filippine 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
ZA - Sudafrica 2
BY - Bielorussia 1
BZ - Belize 1
CO - Colombia 1
CY - Cipro 1
DZ - Algeria 1
EC - Ecuador 1
ES - Italia 1
ET - Etiopia 1
GR - Grecia 1
IL - Israele 1
JM - Giamaica 1
KE - Kenya 1
NP - Nepal 1
OM - Oman 1
PE - Perù 1
SE - Svezia 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TN - Tunisia 1
TR - Turchia 1
UA - Ucraina 1
UZ - Uzbekistan 1
Totale 1.434
Città #
San Jose 80
Singapore 70
Hong Kong 68
Rome 68
Ashburn 42
Hefei 30
Beijing 21
Boardman 18
Lauterbourg 14
Shanghai 14
Dallas 11
London 11
Hanoi 10
Los Angeles 8
Council Bluffs 6
Ho Chi Minh City 6
São Paulo 6
Mexico City 5
Milan 5
Yeonsu-gu 5
Jinan 4
Brno 3
Munich 3
San Francisco 3
Santa Clara 3
Amman 2
Amsterdam 2
Blumenau 2
Da Nang 2
Helsinki 2
Johannesburg 2
New York 2
Pune 2
Rio de Janeiro 2
Safi 2
Sydney 2
Vĩnh Long 2
Abha 1
Addis Ababa 1
Alagoinhas 1
Athens 1
Atyrá 1
Avellaneda 1
Bagé 1
Barra do Garças 1
Barra do Piraí 1
Beni Khalled 1
Biñan 1
Boston 1
Boydton 1
Brasília 1
Bratislava 1
Buffalo 1
Bình Dương 1
Campinas 1
Campo Grande 1
Can Tho 1
Canberra 1
Carlópolis 1
Casablanca 1
Caxias do Sul 1
Cesena 1
Charlotte 1
Chicago 1
Chittagong 1
Ciudad del Este 1
Claypole 1
Conselheiro Lafaiete 1
Contagem 1
Dehradun 1
Dhaka 1
Djelfa 1
Faisalabad 1
Fortaleza 1
Francisco Morato 1
Franco da Rocha 1
Gravataí 1
Guaratuba 1
Guarulhos 1
Guayaquil 1
Guernica 1
Huế 1
Hải Dương 1
Isidro Casanova 1
Islamabad 1
Istanbul 1
Itambé 1
Itápolis 1
Jeddah 1
José Bonifácio 1
Karachi 1
Kathmandu 1
Kingston 1
Kirkuk 1
Lahore 1
Langfang 1
Limassol 1
Lấp Vò 1
Macaúbas 1
Maringá 1
Totale 601
Nome #
ADDIO-BTcP " Evaluation of an UCBM Algorithm-Driven calculator of initial rapid-onset opioids Dose in Italian Oncological patients suffering from breakthrough cancer pain (BTcP): a randomized, multicentric, prospective, phase II trial” 241
A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable 231
Alternative dosing schedules for sunitinib as a treatment of patients with metastatic renal cell carcinoma 210
Anti-EGFR Therapy in Metastatic Small Bowel Adenocarcinoma: Myth or Reality? 152
Another side of the association between body mass index (BMI) and clinical outcomes of cancer patients receiving programmed cell death protein-1 (PD-1)/Programmed cell death-ligand 1 (PD-L1) checkpoint inhibitors: A multicentre analysis of immune-related adverse events 92
PD-1/PD-L1 checkpoint inhibitors during late stages of life: an ad-hoc analysis from a large multicenter cohort 62
Denosumab for cancer-related bone loss 56
Prognostic and predictive role of neutrophil/lymphocytes ratio in metastatic colorectal cancer: a retrospective analysis of the TRIBE study by GONO 55
Early fatigue in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: an insight from clinical practice 47
Clinical Outcomes of Patients with Advanced Cancer and Pre-Existing Autoimmune Diseases Treated with Anti-Programmed Death-1 Immunotherapy: A Real-World Transverse Study 47
Breakthrough Cancer Pain Clinical Features and Differential Opioids Response: A Machine Learning Approach in Patients With Cancer From the IOPS-MS Study 47
Prognostic and predictive factors in pancreatic cancer 46
Evaluating the role of FAMIly history of cancer and diagnosis of multiple neoplasms in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: the multicenter FAMI-L1 study 40
Second-line chemotherapy for advanced pancreatic cancer: Which is the best option? 39
Correlations Between the Immune-related Adverse Events Spectrum and Efficacy of Anti-PD1 Immunotherapy in NSCLC Patients 38
Movement-Based Interventions in Patients Affected by Bone Metastases: Impact on Physical Function and Functional Autonomy—A Systematic Review 36
Totale 1.439
Categoria #
all - tutte 7.521
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.521


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202216 0 0 0 0 1 0 0 0 1 0 0 14
2022/20231 0 0 0 0 0 0 0 0 0 0 1 0
2023/202460 0 5 1 3 3 24 0 6 1 0 0 17
2024/2025799 8 9 18 6 2 14 7 3 46 48 333 305
2025/2026563 49 25 37 67 35 29 177 26 63 55 0 0
Totale 1.439